- Home
- BCG vs ICCC Comparison
BCG vs ICCC Comparison
Compare BCG & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- ICCC
- Stock Information
- Founded
- BCG 2016
- ICCC 1982
- Country
- BCG United States
- ICCC United States
- Employees
- BCG N/A
- ICCC N/A
- Industry
- BCG
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- BCG
- ICCC Health Care
- Exchange
- BCG Nasdaq
- ICCC Nasdaq
- Market Cap
- BCG 42.3M
- ICCC 48.3M
- IPO Year
- BCG N/A
- ICCC 1987
- Fundamental
- Price
- BCG $2.27
- ICCC $5.50
- Analyst Decision
- BCG
- ICCC
- Analyst Count
- BCG 0
- ICCC 0
- Target Price
- BCG N/A
- ICCC N/A
- AVG Volume (30 Days)
- BCG 48.5K
- ICCC 39.0K
- Earning Date
- BCG 05-26-2025
- ICCC 05-14-2025
- Dividend Yield
- BCG N/A
- ICCC N/A
- EPS Growth
- BCG N/A
- ICCC N/A
- EPS
- BCG N/A
- ICCC N/A
- Revenue
- BCG $164,877,000.00
- ICCC $26,493,169.00
- Revenue This Year
- BCG N/A
- ICCC N/A
- Revenue Next Year
- BCG N/A
- ICCC N/A
- P/E Ratio
- BCG N/A
- ICCC N/A
- Revenue Growth
- BCG 1.25
- ICCC 51.63
- 52 Week Low
- BCG $1.71
- ICCC $3.34
- 52 Week High
- BCG $12.22
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- BCG N/A
- ICCC 58.30
- Support Level
- BCG N/A
- ICCC $4.63
- Resistance Level
- BCG N/A
- ICCC $5.55
- Average True Range (ATR)
- BCG 0.00
- ICCC 0.37
- MACD
- BCG 0.00
- ICCC 0.03
- Stochastic Oscillator
- BCG 0.00
- ICCC 79.82
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.